Marker Therapeutics (MRKR) Cash & Current Investments (2010 - 2026)
Marker Therapeutics (MRKR) posted Cash & Current Investments of $11.33 million for Q2 2026, down 4.1% from $11.81 million a year earlier and down 24.0% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Marker Therapeutics' Cash & Current Investments came in at $16.07 million, down 16.3% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -5.5% (FY2020 to FY2025).
- In prior years, Marker Therapeutics' Cash & Current Investments was $19.19 million in FY2024 (+27.0%), $15.11 million in FY2023 (+28.3%), $11.78 million in FY2022 (-72.2%) and $42.35 million in FY2021 (+98.3%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments since Q3 2024.
- On a year-over-year basis, Cash & Current Investments increased in five of the last eight quarters, with growth averaging 16.9%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2021, with growth of 98.3%; the weakest was Q1 2023, with a decline of 77.6%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $14.92 million (Q1 2026), $16.07 million (Q4 2025) and $17.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Marker Therapeutics | 17.53 Mn | -42.37 Mn | - | 11.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.33 Mn |
| Mar 31, 2026 | 14.92 Mn |
| Dec 31, 2025 | 16.07 Mn |
| Sep 30, 2025 | 17.59 Mn |
| Jun 30, 2025 | 11.81 Mn |
| Mar 31, 2025 | 13.69 Mn |
| Dec 31, 2024 | 19.19 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 7.80 Mn |
| Mar 31, 2024 | 11.32 Mn |
| Dec 31, 2023 | 15.11 Mn |
| Sep 30, 2023 | 17.50 Mn |
| Jun 30, 2023 | 18.12 Mn |
| Mar 31, 2023 | 6.40 Mn |
| Dec 31, 2022 | 11.78 Mn |
| Sep 30, 2022 | 18.10 Mn |
| Jun 30, 2022 | 25.82 Mn |
| Mar 31, 2022 | 28.64 Mn |
| Dec 31, 2021 | 42.35 Mn |
| Sep 30, 2021 | 48.71 Mn |
API Access
Marker Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();